Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 98,182 shares at $47.29 ($4.6M) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $4.6M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.29 | 20,275 | $959K | 20.6% |
| 2 | $47.29 | 20,275 | $959K | 20.6% |
| 3 | $47.39 | 11,202 | $531K | 11.4% |
| 4 | $47.39 | 11,202 | $531K | 11.4% |
| 5 | $48.07 | 1,600 | $77K | 1.7% |
| 6 | $48.09 | 1,298 |
| $62K |
| 1.3% |
| 7 | $48.09 | 1,298 | $62K | 1.3% |
| 8 | $47.24 | 15,384 | $727K | 15.6% |
| 9 | $47.24 | 15,384 | $727K | 15.6% |
| 10 | $47.83 | 132 | $6K | 0.1% |
| 11 | $47.83 | 132 | $6K | 0.1% |
| Total | $47.33 avg | 98,182 | $4.6M | 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |